» Articles » PMID: 15086532

Identification of a Novel Family of G Protein-coupled Receptor Associated Sorting Proteins

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2004 Apr 17
PMID 15086532
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

During the past few years several new interacting partners for G protein-coupled receptors (GPCRs) have been discovered, suggesting that the activity of these receptors is more complex than previously anticipated. Recently, candidate G protein-coupled receptor associated sorting protein (GASP-1) has been identified as a novel interacting partner for the delta opioid receptor and has been proposed to determine the degradative fate of this receptor. We show here that GASP-1 associates in vitro with other opioid receptors and that the interaction domain in these receptors is restricted to a small portion of the carboxyl-terminal tail, corresponding to helix 8 in the three-dimensional structure of rhodopsin. In addition, we show that GASP-1 interacts with COOH-terminus of several other GPCRs from subfamilies A and B and that two conserved residues within the putative helix 8 of these receptors are critical for the interaction with GASP-1. In situ hybridization and northern blot analysis indicate that GASP-1 mRNA is mainly distributed throughout the central nervous system, consistent with a potential interaction with numerous GPCRs in vivo. Finally, we show that GASP-1 is a member of a novel family comprising at least 10 members, whose genes are clustered on chromosome X. Another member of the family, GASP-2, also interacts with the carboxyl-terminal tail of several GPCRs. Therefore, GASP proteins may represent an important protein family regulating GPCR physiology.

Citing Articles

GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to paclitaxel by forming a vicious cycle with IGF1/IGF1R signaling pathway.

Liu Z, Meng D, Wang J, Cao H, Feng P, Wu S Cell Death Dis. 2022; 13(8):751.

PMID: 36042202 PMC: 9427794. DOI: 10.1038/s41419-022-05198-6.


International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Barnes N, Ahern G, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S Pharmacol Rev. 2020; 73(1):310-520.

PMID: 33370241 PMC: 7770494. DOI: 10.1124/pr.118.015552.


Review of the Endocannabinoid System.

Lu H, Mackie K Biol Psychiatry Cogn Neurosci Neuroimaging. 2020; 6(6):607-615.

PMID: 32980261 PMC: 7855189. DOI: 10.1016/j.bpsc.2020.07.016.


Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R).

Fletcher-Jones A, Hildick K, Evans A, Nakamura Y, Henley J, Wilkinson K Front Mol Neurosci. 2020; 13:108.

PMID: 32595453 PMC: 7304349. DOI: 10.3389/fnmol.2020.00108.


The Delta-Opioid Receptor; a Target for the Treatment of Pain.

Quirion B, Bergeron F, Blais V, Gendron L Front Mol Neurosci. 2020; 13:52.

PMID: 32431594 PMC: 7214757. DOI: 10.3389/fnmol.2020.00052.